 | This article relies largely or entirely on a single source .(July 2019) |
 | |
| Clinical data | |
|---|---|
| Other names | 2-Ethoxy-4,5-dimethoxyamphetamine |
| Routes of administration | Oral [1] |
| ATC code |
|
| Pharmacokinetic data | |
| Duration of action | Unknown [1] |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C13H21NO3 |
| Molar mass | 239.315 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
EMM, also known as 2-ethoxy-4,5-dimethoxyamphetamine, is a substituted amphetamine. [1] It is a dimethoxy-ethoxy analogue of trimethoxyamphetamine (TMA-2). [1] EMM was first synthesized by Alexander Shulgin. [1] In his book PiHKAL , both the dose and duration are unknown. [1] EMM produces few to no effects. [1] Very little data exists about the pharmacological properties, metabolism, and toxicity of EMM. [1]
